Evolent Health (EVH) executive compensation, 2026 proxy

Seth Blackley, Chief Executive Officer, was paid $14.2M in 2025, up 28% from $11.1M the year before. The CEO-to-median-employee pay ratio was 193:1, on median employee pay of $74,011.

Filed
April 24, 2026
Annual meeting
June 4, 2026
Pay year
2025
Named executives
5
CEO total pay
$14.2M+28% vs prior year
CEO to median employee
193:1median $74,011
CEO pay in equity
89%$12.7M in awards
Prior say-on-pay support
88%of votes cast
2025 Revenue
$1,876.2MFinancial performance highlight
2025 Adjusted EBITDA
$151.2MNon-GAAP measure
Say-on-Pay Approval
88.3%Prior year support
CEO Total Compensation
$14.2MFor fiscal 2025

How Blackley was paid

$14.2M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary6%Bonus5%Stock awards89%All other compensation0%

Named executive officers

ExecutiveTotal
Seth BlackleyChief Executive Officer$14,240,154
John JohnsonFormer Chief Financial Officer; Chief Strategy Officer$5,370,671
Daniel McCarthyPresident$9,623,279
Emily RaffertyFormer Chief Operating Officer; EVP, Customer Success$2,404,625
Jonathan WeinbergGeneral Counsel$2,639,664

What changed and why

  • $1,876.2MRevenue reached $1,876.2 million alongside an Adjusted EBITDA of $151.2 million for fiscal year 2025.
  • $14.2MCEO total compensation increased to $14,240,154 in 2025 from $11,136,185 in 2024.
  • 88.3%The advisory say-on-pay vote received approximately 88.3% approval from stockholders in 2025.
  • The compensation committee shifted more target total compensation to cash while decreasing equity grants.
  • Total shareholder return relative to the S&P SmallCap 600 Index is used for PSU grants.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.